Search
01/04/2026
Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children
Gnech, M, Bujons, A, Radmayr, C, Hoen, L, Bogaert, G, Burgu, B, Rawashdeh, YF, Silay, MS, O'Kelly, F, Quaedackers, J, Pakkasjärvi, N, van Uitert, A, Skott, M, Kennedy, U, Yuan, YH, Zachou, A, Castagnetti, M. Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children. Journal of Pediatric Urology. 2026; 22(2)DOI:10.1016/j.jpurol.2025.06.016. PMID:40615247. IF:1.900(Q2/5D).
01/04/2026
Barriers to pregnancy and parenthood during urology residency across Europe
Afferi, L, Margue, G, Toribio-Vázquez, C, Melsert, BM, Baekelandt, L, Goujon, A, Ozalevli, M, Checcucci, E, Lazos, AG, Siech, C, Vásquez, JL, Mertens, LS, Liatsikos, E, Somani, BK, Pradere, B, Whitburn, J, Wyler, S, Breda, A, Phé, V, Weissman, JS, Rangel, E. Barriers to pregnancy and parenthood during urology residency across Europe. Bjui Compass. 2026; 7(4)DOI:10.1002/bco2.70181. PMID:42022230. IF:(Q/D).
01/04/2026
Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)
González, JG, Magaña, JG, Llàcer, P, Pal, AF, Trullàs, JC, Zegrí-Reiriz, I, Díez-Villanueva, P, Fernandez, AE, Manzano, LP, Fernández, ABM, Pérez, PC, López-Azor, JC, Martínez, R, D'Amato, M, Pascual, CF, Ruiz-Ruiz, E, Pisón, EP, Anter, MB, Marcos, MC. Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI). ESC Heart Failure. 2026; 13(2)DOI:10.1093/eschf/xvag096. PMID:41920937. IF:3.700(Q1/3D).
01/04/2026
Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Synowiec, E, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk
Vallès-Cardona, G, Caixàs, A, Berges, I, Perea, G, Vilalta, N, Corripio, R. Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk. GENETICS IN MEDICINE. 2026; 28(4)DOI:10.1016/j.gim.2026.102536. PMID:41685566. IF:6.200(Q1/1D).
01/04/2026
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
Gorog, DA, ten Berg, JM, Campo, G, Geisler, T, Gigante, B, Grove, EL, Halvorsen, S, Huber, K, Jeong, YH, Lip, GYH, Navarese, EP, Rubboli, A, Matula, JMS, Storey, RF, Valgimigli, M, Vandenbriele, C, Vilahur, G, Ahrens, I, Ferreiro, JL. Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuag021. PMID:41914626. IF:4.600(Q1/2D).
01/04/2026
Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction
Leader, JH, Vilahur, G, Ajjan, RA, Kanji, R, Gue, YX, Farag, M, Gorog, DA. Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction. CARDIOVASCULAR RESEARCH. 2026; 122(6)DOI:10.1093/cvr/cvag047. PMID:41757699. IF:13.300(Q1/1D).
01/04/2026
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
Marques-Pamies, M, Ricou, L, Gil, J, Sampedro-Núñez, M, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Torres, A, Librizzi, S, Calatayud, M, Novoa, PD, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Valassi, E, Puig-Domingo, M. Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study. Journal Of The Endocrine Society. 2026; 10(4)DOI:10.1210/jendso/bvag030. PMID:41798894. IF:(Q/D).
01/04/2026
Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain
Araujo-Castro, M, Garcia-Centeno, R, Fernández, LG, Soto-Moreno, A, Camara, R, García, MDO, Echarri, AI, Gracia, P, Pascual-Corrales, E, Biagetti, B, Cardona, A, Molero, IG, Simo-Servat, A, Guerrero-Perez, F, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Novo-Rodríguez, C, Tenorio-Jimenéz, C, Calatayud, M, Rodríguez, MDM, Cordido, F, Castro, A, Valero, LM, Paja, M, Goi, J, Aulinas, A, Abellán, P, Iglesias, P, Hanzu, FA. Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2026; 49(4)DOI:10.1007/s40618-025-02769-0. PMID:41335191. IF:3.500(Q2/4D).
01/04/2026
Question: A striking central venous pressure waveform leading to the diagnosis
Ferrer-Menéndez, M, Taroncher-Domingo, C, Duran-Cambra, A. Question: A striking central venous pressure waveform leading to the diagnosis. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuaf149. PMID:41883263. IF:4.600(Q1/2D).
01/04/2026
Answer: A striking central venous pressure waveform leading to the diagnosis
Ferrer-Menéndez, M, Taroncher-Domingo, C, Duran-Cambra, A. Answer: A striking central venous pressure waveform leading to the diagnosis. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuaf150. PMID:41922903. IF:4.600(Q1/2D).
01/04/2026
Heart Transplantation in Cardiac Amyloidosis. Management and Outcomes. Data from the Spanish Heart Transplant Registry
Ballesteros, MA, Barge-Caballero, G, Herrador, L, Gomez-Bueno, M, Caravaca, P, de Antonio-Ferrer, M, Vilella, RL, Rivas, S, Manrique-Antón, R, Palacios-Castelló, C, Cobo-Belaustegui, M, Crespin-Crespin, M, de la Fuente-galán, L, de Sanmamed-Girón, MF, Ortiz-Bautista, C, Diaz-Molina, B, Blasco-Peiró, T, Barge-Caballero, E, Crespo-LeiroServicio, MG. Heart Transplantation in Cardiac Amyloidosis. Management and Outcomes. Data from the Spanish Heart Transplant Registry. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes
Cosio, MG, Severo, A, Gonzalez-Vilchez, F, Lopez-Vilella, R, Bueno, MG, Couto-Mallon, D, Blazquez, Z, Caravaca, P, Alarcos, H, Molina, BD, Romero, EG, Perez, SM, Marquez, MS, Bravo, IG, Tobar, J, Peiro, MB, Muñiz, J, Delgado, J. Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Wypych-Zych, A, Jean-Baptiste, G, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Ibero, J, Topciu, T, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice
Olveira, A, Crespo, J, Ibañez-Samaniego, L, Gallego-Durán, R, Calleja, JL, Aller, R, Soria, A, Gómez-Camarero, J, Martín-Mateos, R, Benlloch, S, Pericàs, JM, Morillas, RM, Bernal-Monterde, V, Diago, M, Turnes, J, Poca, M, Lo Iacono, O, Maya-Miles, D, Escudero, D, Andrade, RJ, Rosales, JM, Jorquera, F, Fernández-Rodriguez, C, Hernández-Guerra, M, Romero-Gómez, M, Ampuero, J. Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice. Clinical Gastroenterology and Hepatology. 2026; 24(4)DOI:10.1016/j.cgh.2025.08.023. PMID:40907848. IF:12.000(Q1/1D).
01/04/2026
Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations
Ramudo-Cela, L, Izquierdo-García, M, Dolores-Sequedo, M, Cubells-Perez, V, Bernal, S, Riera, P, Lasa, A, Torres-Juan, L, Asensio, VJ, Martínez-López, I, de Hevia, AO, Morín, M, Moreno-Pelayo, MA, Carmona-Antoñanzas, G, Pelayo, JP. Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations. Pharmaceuticals. 2026; 19(4)DOI:10.3390/ph19040568. PMID:42075824. IF:4.800(Q1/2D).
01/04/2026
Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy
Panadés-de Oliveira, L, Galeote, MS, Duran, EP, Vilella, L, Garcia, ACD, Principe, A, Metje, AP, Marti, IC, Pérez-Jurado, LA, Zucca, R, Boronat, S, Rocamora, R. Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2026; 137DOI:10.1016/j.seizure.2026.02.021. PMID:41785580. IF:2.800(Q2/5D).
01/04/2026
Risk of delayed atrioventricular block in patients without procedural conduction disturbances during transcatheter aortic valve replacement
Fischer, Q, Nombela-Franco, L, Muntané-Carol, G, Veiga, G, Regueiro, A, Nazif, T, Serra, V, Asmarats, L, Ribeiro, HB, Latib, A, Poulin, A, Cheema, AN, Jiménez-Quevedo, P, Gomez-Hospital, JA, Ongay, AG, Ruberti, A, Arzamendi, D, Brener, M, Calabuig, A, Scotti, A, Gelain, MAS, Labinaz, M, Cepas-Guillén, P, Côté, M, del Portillo, JH, Philippon, F, Rodés-Cabau, J. Risk of delayed atrioventricular block in patients without procedural conduction disturbances during transcatheter aortic valve replacement. HEART RHYTHM. 2026; 23(4)DOI:10.1016/j.hrthm.2025.04.017. PMID:40239910. IF:5.700(Q1/2D).
01/04/2026
Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management
Pascual-Figal, DA, García-Serna, AM, Esteban-Gil, A, Fuster, JJ, Martín, P, Sánchez-Cabo, F, Uribarri, A, Iniesta-Manjavacas, AM, Larrañaga-Moreira, JM, Lopez-Fernandez, S, Pastor-Pueyo, P, Diez-Lopez, C, Flórez, JMV, Bueno, H, Sanmartin-Fernandez, M, Fernández-Martínez, J, Alvarez, BA, Martinez, AT, Domínguez, F. Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management. ESC Heart Failure. 2026; 13(2)DOI:10.1093/eschf/xvag022. PMID:41711201. IF:3.700(Q1/3D).